New immune oncology drug molecules expected to result from leadXpro / InterAx partnership

The innovative RFID-based solution for prefilled syringes (PFS) aims to boost efficiency and enhance traceability during the fill-and-finish process and product distribution

Alithea Genomics, a leader in large-scale RNA sequencing, received a loan guarantee from Switzerland's Technology Fund, aiding its growth. The fund, part of the Swiss Federal Office for the Environment, supports companies reducing greenhouse gas emissions. Alithea's innovative technologies, such as BRB-seq and DRUG-seq, cut costs, time, and resource use in RNA sequencing, promoting sustainability.

Industrial biotechnology promotes more energy-efficient and sustainable manufacturing processes as well as creating opportunities for reducing pollution, reusing waste and creating new products. It underpins a circular economy and a more sustainable chemicals industry which prioritizes protecting scarce natural resources. New bio-based products and processes have far-reaching and disruptive impact

Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has received three grants totaling more than CHF 1.3 million from Innosuisse Swiss Innovation Agency, Target ALS and the ALS Association.

ten23 health, a leading Swiss contract development and manufacturing organization (CDMO), yesterday proudly hosted the Grand Opening of its VIVA2 facility in Visp, Switzerland.